Annual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB (publ) on 6 May 2021 voted, among other things, to approve the following resolutions: · adoption of the annual report · discharge from liability for the Board members and the CEO · a dividend of SEK 3.41 per share and a grant of SEK 2.8 million to “The Foundation to Prevent Antibiotic Resistance” that was founded by BioGaia in 2017. The purpose of the foundation is to reduce antibiotic resistance through support to research, education and information activities that promote of the use of products and methods that prevent and therefore